Montagna, Giacomo
Sevilimedu, Varadan
Fornier, Monica
Jhaveri, Komal
Morrow, Monica
Pilewskie, Melissa L.
Funding for this research was provided by:
NIH/NCI Cancer Center Support Grant (P30 CA008748)
Article History
Received: 11 May 2020
Accepted: 30 June 2020
First Online: 24 August 2020
Disclosures
: Dr. Monica Morrow has received speaking honoraria from Genomic Health. Dr. Giacomo Montagna was supported by the Ticino Cancer League, the Hanne Liebermann Foundation, the Fondation Ancrage, and the HEMMI-Stiftung. Dr. Komal Jhaveri has a consulting or advisory role with Novartis, Pfizer, Genentech, Lilly Pharmaceuticals, Astra Zeneca, Bristol-Myers Squibb, ADC Therapeutics, Taiho Oncology, Jounce Therapeutics, and Abbvie, and research funding (to the institution) from Pfizer, Genentech, Novartis, Lilly Pharmaceuticals, Astra Zeneca, Immunomedics, Puma Biotechnology, Novita Pharmaceuticals, ADC Therapeutics, Zymeworks, Debio Pharmaceuticals, and Clovis Oncology. The remaining authors have no conflicts of interest.